{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:16:26Z","timestamp":1791249386436,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1038\/ncpneuro0913","type":"journal-article","created":{"date-parts":[[2008,10,3]],"date-time":"2008-10-03T06:44:37Z","timestamp":1223016277000},"page":"568-577","source":"Crossref","is-referenced-by-count":139,"title":["McArdle disease: what do neurologists need to know?"],"prefix":"10.1038","volume":"4","author":[{"given":"Alejandro","family":"Lucia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Nogales-Gadea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni L","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpneuro0913_CR1","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1001\/archneur.57.7.923","volume":"57","author":"RG Haller","year":"2000","unstructured":"Haller RG (2000) Treatment of McArdle disease. Arch Neurol 57: 923\u2013924","journal-title":"Arch Neurol"},{"key":"BFncpneuro0913_CR2","first-page":"13","volume":"10","author":"B McArdle","year":"1951","unstructured":"McArdle B (1951) Myopathy due to a defect in muscle glycogen breakdown. Clin Sci 10: 13\u201333","journal-title":"Clin Sci"},{"key":"BFncpneuro0913_CR3","first-page":"53","volume":"26","author":"AL Andreu","year":"2007","unstructured":"Andreu AL  et al. (2007) McArdle disease: molecular genetic update. Acta Myol 26: 53\u201357","journal-title":"Acta Myol"},{"key":"BFncpneuro0913_CR4","first-page":"35","volume":"26","author":"S DiMauro","year":"2007","unstructured":"DiMauro S (2007) Muscle glycogenoses: an overview. Acta Myol 26: 35\u201341","journal-title":"Acta Myol"},{"key":"BFncpneuro0913_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ymgme.2005.03.002","volume":"85","author":"PJ Isackson","year":"2005","unstructured":"Isackson PJ  et al. (2005) A novel mutation in the PYGM gene in a family with pseudo-dominant transmission of McArdle disease. Mol Genet Metab 85: 239\u2013242","journal-title":"Mol Genet Metab"},{"key":"BFncpneuro0913_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJM199307223290404","volume":"329","author":"S Tsujino","year":"1993","unstructured":"Tsujino S  et al. (1993) Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease). N Engl J Med 329: 241\u2013245","journal-title":"N Engl J Med"},{"key":"BFncpneuro0913_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/1566524024605770","volume":"2","author":"S DiMauro","year":"2002","unstructured":"DiMauro S  et al. (2002) Myophosphorylase deficiency (glycogenosis type V; McArdle disease). Curr Mol Med 2: 189\u2013196","journal-title":"Curr Mol Med"},{"key":"BFncpneuro0913_CR8","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1056\/NEJMoa031836","volume":"349","author":"J Vissing","year":"2003","unstructured":"Vissing J and Haller RG (2003) The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. N Engl J Med 349: 2503\u20132509","journal-title":"N Engl J Med"},{"key":"BFncpneuro0913_CR9","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1002\/mus.10377","volume":"27","author":"J Zange","year":"2003","unstructured":"Zange J  et al. (2003) Breakdown of adenine nucleotide pool in fatiguing skeletal muscle in McArdle's disease: a noninvasive 31P-MRS and EMG study. Muscle Nerve 27: 728\u2013736","journal-title":"Muscle Nerve"},{"key":"BFncpneuro0913_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1152\/jappl.1986.61.2.391","volume":"61","author":"SF Lewis","year":"1986","unstructured":"Lewis SF and Haller RG (1986) The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue. J Appl Physiol 61: 391\u2013401","journal-title":"J Appl Physiol"},{"key":"BFncpneuro0913_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1212\/WNL.50.1.37","volume":"50","author":"Haller","year":"1998","unstructured":"Haller  et al. (1998) Reduced levels of skeletal muscle Na+K+-ATPase in McArdle disease. Neurology 50: 37\u201340","journal-title":"Neurology"},{"key":"BFncpneuro0913_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/ana.10499","volume":"53","author":"A Martinuzzi","year":"2003","unstructured":"Martinuzzi A  et al. (2003) Phenotype modulators in myophosphorylase deficiency. Ann Neurol 53: 497\u2013502","journal-title":"Ann Neurol"},{"key":"BFncpneuro0913_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.neulet.2007.06.025","volume":"422","author":"JC Rubio","year":"2007","unstructured":"Rubio JC  et al. (2007) Genotype modulators of clinical severity in McArdle disease. Neurosci Lett 422: 217\u2013222","journal-title":"Neurosci Lett"},{"key":"BFncpneuro0913_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/JSM.0b013e3180f6168c","volume":"17","author":"JL Mat\u00e9-Mu\u00f1oz","year":"2007","unstructured":"Mat\u00e9-Mu\u00f1oz JL  et al. (2007) Favorable responses to acute and chronic exercise in McArdle patients. Clin J Sport Med 17: 297\u2013303","journal-title":"Clin J Sport Med"},{"key":"BFncpneuro0913_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neulet.2005.08.026","volume":"31","author":"C Paradas","year":"2005","unstructured":"Paradas C  et al. (2005) Variable presentation of the clinical phenotype of McArdle's disease in a kindred harbouring a novel compound genotype in the muscle glycogen phosphorylase gene. Neurosci Lett 31: 28\u201331","journal-title":"Neurosci Lett"},{"key":"BFncpneuro0913_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1155\/2004\/934024","volume":"11","author":"N Voduc","year":"2004","unstructured":"Voduc N  et al. (2004) McArdle's disease presenting as unexplained dyspnea in a young woman. Can Respir J 11: 163\u2013167","journal-title":"Can Respir J"},{"key":"BFncpneuro0913_CR17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/35001141","volume":"403","author":"AG Williams","year":"2000","unstructured":"Williams AG  et al. (2000) The ACE gene and muscle performance. Nature 403: 614","journal-title":"Nature"},{"key":"BFncpneuro0913_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/bjsm.2007.038992","volume":"42","author":"F G\u00f3mez-Gallego","year":"2008","unstructured":"G\u00f3mez-Gallego F  et al. (2008) The I allele of the ACE gene is associated with improved exercise capacity in women with McArdle disease. Br J Sports Med 42: 134\u2013140","journal-title":"Br J Sports Med"},{"key":"BFncpneuro0913_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0960-8966(94)00062-E","volume":"15","author":"S Tsujino","year":"1995","unstructured":"Tsujino S  et al. (1995) Double trouble: combined myophosphorylase and AMP deaminase deficiency in a child homozygous for nonsense mutations at both loci. Neuromuscul Disord 15: 263\u2013266","journal-title":"Neuromuscul Disord"},{"key":"BFncpneuro0913_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1055\/s-2007-965358","volume":"29","author":"JC Rubio","year":"2008","unstructured":"Rubio JC  et al. (2008) AMPD1 genotypes and exercise capacity in McArdle patients. Int J Sports Med 29: 331\u2013335","journal-title":"Int J Sports Med"},{"key":"BFncpneuro0913_CR21","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1177\/0883073807304206","volume":"22","author":"M P\u00e9rez","year":"2007","unstructured":"P\u00e9rez M  et al. (2007) Exercise capacity in a child with McArdle disease. J Child Neurol 22: 880\u2013882","journal-title":"J Child Neurol"},{"key":"BFncpneuro0913_CR22","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1212\/WNL.28.11.1124","volume":"28","author":"S DiMauro","year":"1978","unstructured":"DiMauro S and Hartlage PL (1978) Fatal infantile form of muscle phosphorylase deficiency. Neurology 28: 1124\u20131129","journal-title":"Neurology"},{"key":"BFncpneuro0913_CR23","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/bjsm.2006.026666","volume":"40","author":"M P\u00e9rez","year":"2006","unstructured":"P\u00e9rez M  et al. (2006) Exercise capacity in a 78 year old patient with McArdle's disease: it is never too late to start exercising. Br J Sports Med 40: 725\u2013726","journal-title":"Br J Sports Med"},{"key":"BFncpneuro0913_CR24","first-page":"1554","volume-title":"Myology","author":"S DiMauro","year":"1995","unstructured":"DiMauro S and Tsujino S (1995) Nonlysosomal glycogenoses. In Myology, 1554\u20131556 (Eds Engel AG and Franzini-Armstrong C) New York: McGraw-Hill"},{"key":"BFncpneuro0913_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000116937","volume":"33","author":"K Jinnai","year":"1993","unstructured":"Jinnai K  et al. (1993) Glycogenosis type V (McArdle's disease) with hyperuricemia: a case report and clinical investigation. Eur Neurol 33: 204\u2013207","journal-title":"Eur Neurol"},{"key":"BFncpneuro0913_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1056\/NEJM198707093170203","volume":"317","author":"I Mineo","year":"1987","unstructured":"Mineo I  et al. (1987) Myogenic hyperuricemia: a common pathophysiologic feature of glycogenosis types III, V, and VII. N Engl J Med 317: 75\u201380","journal-title":"N Engl J Med"},{"key":"BFncpneuro0913_CR27","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1399-6576.2005.00755.x","volume":"49","author":"G Bollig","year":"2005","unstructured":"Bollig G  et al. (2005) McArdle's disease and anaesthesia: case reports: review of potential problems and association with malignant hyperthermia. Acta Anaesthesiol Scand 49: 1077\u20131083","journal-title":"Acta Anaesthesiol Scand"},{"key":"BFncpneuro0913_CR28","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1590\/S0004-282X2007000500020","volume":"65","author":"PJ Lorenzoni","year":"2007","unstructured":"Lorenzoni PJ  et al. (2007) McArdle disease with rhabdomyolysis induced by rosuvastatin: case report [Portuguese]. Arq Neuropsiquiatr 65: 834\u2013837","journal-title":"Arq Neuropsiquiatr"},{"key":"BFncpneuro0913_CR29","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/0002-9343(61)90075-4","volume":"30","author":"C Pearson","year":"1961","unstructured":"Pearson C  et al. (1961) A metabolic myopathy due to absence of muscle phosphorylase. Am J Med 30: 502\u2013517","journal-title":"Am J Med"},{"key":"BFncpneuro0913_CR30","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1001\/archneur.59.9.1395","volume":"59","author":"RG Haller","year":"2002","unstructured":"Haller RG and Vissing J (2002) Spontaneous 'second wind' and glucose-induced second 'second wind' in McArdle disease: oxidative mechanisms. Arch Neurol 59: 1395\u20131402","journal-title":"Arch Neurol"},{"key":"BFncpneuro0913_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1212\/WNL.62.1.82","volume":"62","author":"RG Haller","year":"2004","unstructured":"Haller RG and Vissing J (2004) No spontaneous second wind in muscle phosphofructokinase deficiency. Neurology 62: 82\u201386","journal-title":"Neurology"},{"key":"BFncpneuro0913_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1056\/NEJM199102073240603","volume":"324","author":"RG Haller","year":"1991","unstructured":"Haller RG and Lewis SF (1991) Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. N Engl J Med 324: 364\u2013369","journal-title":"N Engl J Med"},{"key":"BFncpneuro0913_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/ana.10725","volume":"54","author":"J Vissing","year":"2003","unstructured":"Vissing J and Haller RG (2003) A diagnostic cycle test for McArdle's disease. Ann Neurol 54: 539\u2013542","journal-title":"Ann Neurol"},{"key":"BFncpneuro0913_CR34","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1212\/01.wnl.0000289190.66955.67","volume":"70","author":"MC \u00d8rngreen","year":"2008","unstructured":"\u00d8rngreen MC  et al. (2008) Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency. Neurology 70: 1872\u20131873","journal-title":"Neurology"},{"key":"BFncpneuro0913_CR35","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/archneur.62.9.1440","volume":"62","author":"J Vissing","year":"2005","unstructured":"Vissing J  et al. (2005) Effects of fuels on exercise capacity in muscle phosphoglycerate mutase deficiency. Arch Neurol 62: 1440\u20131444","journal-title":"Arch Neurol"},{"key":"BFncpneuro0913_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/archneur.62.1.37","volume":"62","author":"M Deschauer","year":"2005","unstructured":"Deschauer M  et al. (2005) Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects. Arch Neurol 62: 37\u201341","journal-title":"Arch Neurol"},{"key":"BFncpneuro0913_CR37","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1212\/WNL.56.12.1779","volume":"56","author":"A Lindner","year":"2001","unstructured":"Lindner A  et al. (2001). Acute compartment syndrome after forearm ischemic work test in a patient with McArdle's disease. Neurology 56: 1779\u20131780","journal-title":"Neurology"},{"key":"BFncpneuro0913_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ana.10263","volume":"52","author":"P Kazemi-Esfarjani","year":"2002","unstructured":"Kazemi-Esfarjani P  et al. (2002) A nonischemic forearm exercise test for McArdle disease. Ann Neurol 52: 153\u2013159","journal-title":"Ann Neurol"},{"key":"BFncpneuro0913_CR39","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/00365517509095787","volume":"35","author":"J Bergstr\u00f6m","year":"1975","unstructured":"Bergstr\u00f6m J (1975) Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 35: 609\u2013616","journal-title":"Scand J Clin Lab Invest"},{"key":"BFncpneuro0913_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11910-007-0026-2","volume":"7","author":"G Nogales-Gadea","year":"2007","unstructured":"Nogales-Gadea G  et al. (2007) Molecular genetics of McArdle's disease. Curr Neurol Neurosci Rep 7: 84\u201392","journal-title":"Curr Neurol Neurosci Rep"},{"key":"BFncpneuro0913_CR41","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/humu.9434","volume":"27","author":"C Bruno","year":"2006","unstructured":"Bruno C  et al. (2006) McArdle disease: the mutation spectrum of PYGM in a large Italian cohort. Hum Mutat 27: 718","journal-title":"Hum Mutat"},{"key":"BFncpneuro0913_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1126\/science.6587566","volume":"225","author":"RV Lebo","year":"1984","unstructured":"Lebo RV  et al. (1984) High-resolution chromosome sorting and DNA spot-blot analysis assign McArdle's syndrome to chromosome 11. Science 225: 57\u201359","journal-title":"Science"},{"key":"BFncpneuro0913_CR43","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/hmg\/2.8.1291","volume":"2","author":"C Bartram","year":"1993","unstructured":"Bartram C  et al. (1993) McArdle's disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases. Hum Mol Genet 2: 1291\u20131293","journal-title":"Hum Mol Genet"},{"key":"BFncpneuro0913_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.nmd.2006.12.014","volume":"17","author":"R Aquaron","year":"2007","unstructured":"Aquaron R  et al. (2007) Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations: absence of genotype-phenotype correlation. Neuromuscul Disord 17: 235\u2013241","journal-title":"Neuromuscul Disord"},{"key":"BFncpneuro0913_CR45","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00415-006-0447-x","volume":"254","author":"M Deschauer","year":"2007","unstructured":"Deschauer M  et al. (2007) Analysis of spectrum and frequencies of mutations in McArdle disease: identification of 13 novel mutations. J Neurol 254: 797\u2013802","journal-title":"J Neurol"},{"key":"BFncpneuro0913_CR46","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.1225","volume":"50","author":"MA Martin","year":"2000","unstructured":"Martin MA  et al. (2000) Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study. Ann Neurol 50: 574\u2013581","journal-title":"Ann Neurol"},{"key":"BFncpneuro0913_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/humu.9474","volume":"28","author":"JC Rubio","year":"2006","unstructured":"Rubio JC  et al. (2006) A proposed molecular diagnostic flowchart for myophosphorylase deficiency (McArdle disease) in blood samples from Spanish patients. Hum Mutat 28: 203\u2013204","journal-title":"Hum Mutat"},{"key":"BFncpneuro0913_CR48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/ajmg.1320540109","volume":"54","author":"S Tsujino","year":"1994","unstructured":"Tsujino S  et al. (1994) Three new mutations in patients with myophosphorylase deficiency (McArdle disease). Am J Hum Genet 54: 44\u201352","journal-title":"Am J Hum Genet"},{"key":"BFncpneuro0913_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1001\/archneur.57.2.217","volume":"57","author":"R Fernandez","year":"2000","unstructured":"Fernandez R  et al. (2000) A novel missense mutation (W797R) in the myophosphorylase gene in Spanish patients with McArdle disease. Arch Neurol 57: 217\u2013219","journal-title":"Arch Neurol"},{"key":"BFncpneuro0913_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0022-510X(99)00091-X","volume":"165","author":"C Bruno","year":"1999","unstructured":"Bruno C  et al. (1999). Molecular characterization of McArdle's disease in two large Finnish families. J Neurol Sci 165: 121\u2013125","journal-title":"J Neurol Sci"},{"key":"BFncpneuro0913_CR51","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1212\/WNL.61.10.1432","volume":"61","author":"I Fernandez-Cadenas","year":"2003","unstructured":"Fernandez-Cadenas I  et al. (2003) Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle disease. Neurology 61: 1432\u20131434","journal-title":"Neurology"},{"key":"BFncpneuro0913_CR52","unstructured":"Garc\u00eda-Consuegra I  et al.: Novel mutations in patients with McArdle disease by analysis of skeletal muscle mRNA. J Med Genet, in press"},{"key":"BFncpneuro0913_CR53","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1212\/WNL.53.6.1352","volume":"53","author":"G Pari","year":"1999","unstructured":"Pari G  et al. (1999) Myophosphorylase gene transfer in McArdle's disease myoblasts in vitro. Neurology 53: 1352\u20131354","journal-title":"Neurology"},{"key":"BFncpneuro0913_CR54","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nmd.2007.10.006","volume":"18","author":"JM Howell","year":"2008","unstructured":"Howell JM  et al. (2008) Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle's disease: expression and re-expression of glycogen phosphorylase. Neuromuscul Disord 18: 248\u2013258","journal-title":"Neuromuscul Disord"},{"key":"BFncpneuro0913_CR55","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/humu.20649","volume":"29","author":"G Nogales-Gadea","year":"2008","unstructured":"Nogales-Gadea G  et al. (2008) Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay. Hum Mutat 29: 277\u2013283","journal-title":"Hum Mutat"},{"key":"BFncpneuro0913_CR56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature05756","volume":"447","author":"EM Welch","year":"2007","unstructured":"Welch EM  et al. (2007) PTC124 targets genetic disorders caused by nonsense mutations. Nature 447: 87\u201391","journal-title":"Nature"},{"key":"BFncpneuro0913_CR57","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1212\/01.wnl.0000194212.31318.fc","volume":"66","author":"A Schroers","year":"2006","unstructured":"Schroers A  et al. (2006). Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficienc. Neurology 66: 285\u2013286","journal-title":"Neurology"},{"key":"BFncpneuro0913_CR58","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mus.20937","volume":"37","author":"A Martinuzzi","year":"2008","unstructured":"Martinuzzi A  et al. (2008) Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease. Muscle Nerve 37: 350\u2013357","journal-title":"Muscle Nerve"},{"key":"BFncpneuro0913_CR59","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/0022-510X(90)90020-N","volume":"100","author":"PJ Poels","year":"1990","unstructured":"Poels PJ  et al. (1990) Dantrolene sodium does influence the second-wind phenomenon in McArdle's disease: electrophysiological evidence during exercise in a double-blind placebo-controlled, cross-over study in 5 patients. J Neurol Sci 100: 108\u2013112","journal-title":"J Neurol Sci"},{"key":"BFncpneuro0913_CR60","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0022-510X(95)00320-2","volume":"136","author":"IC Steele","year":"1996","unstructured":"Steele IC  et al. (1996) A double blind, placebo controlled, cross over trial of D-ribose in McArdle disease. J Neurol Sci 136: 174\u2013177","journal-title":"J Neurol Sci"},{"key":"BFncpneuro0913_CR61","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1001\/archneur.57.7.956","volume":"57","author":"M Vorgerd","year":"2002","unstructured":"Vorgerd M  et al. (2002) Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch Neurol 57: 956\u2013963","journal-title":"Arch Neurol"},{"key":"BFncpneuro0913_CR62","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/archneur.59.1.97","volume":"59","author":"M Vorgerd","year":"2002","unstructured":"Vorgerd M  et al. (2002) Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle disease: double-blind, placebo-controlled crossover study. Arch Neurol 59: 97\u2013101","journal-title":"Arch Neurol"},{"key":"BFncpneuro0913_CR63","doi-asserted-by":"crossref","unstructured":"Andersen ST and Vissing J (2008) Carbohydrate- and protein-rich diets in McArdle disease: effects on exercise capacity. J Neurol Neurosurg Psychiatry [10.1136\/jnnp.2008.146548]","DOI":"10.1136\/adc.2008.146548"},{"key":"BFncpneuro0913_CR64","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1212\/WNL.51.5.1456","volume":"51","author":"D MacLean","year":"1998","unstructured":"MacLean D  et al. (1998) Oral branched chain amino acids do not improve exercise capacity in McArdle's disease. Neurology 51: 1456\u20131459","journal-title":"Neurology"},{"key":"BFncpneuro0913_CR65","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/archneur.65.6.786","volume":"65","author":"ST Andersen","year":"2008","unstructured":"Andersen ST  et al. (2008) Effect of oral sucrose shortly before exercise on work capacity in McArdle disease. Arch Neurol 65: 786\u2013789","journal-title":"Arch Neurol"},{"key":"BFncpneuro0913_CR66","doi-asserted-by":"crossref","unstructured":"Quinlivan R  et al. Pharmacological and nutritional treatment for McArdle disease (glycogen storage disease type V). Cochrane Database Systematic Reviews 2008, Issue 1. Art. No.: CD003458. 10.1002\/14651858.CD003458.pub3","DOI":"10.1002\/14651858.CD003458.pub3"},{"key":"BFncpneuro0913_CR67","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1600-0404.1990.tb01007.x","volume":"81","author":"KE Jensen","year":"1990","unstructured":"Jensen KE  et al. (1990) Kinetics following high protein diet in McArdle's syndrome: a 31P magnetic resonance spectroscopy study. Acta Neurol Scand 81: 499\u2013503","journal-title":"Acta Neurol Scand"},{"key":"BFncpneuro0913_CR68","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1056\/NEJM198502073120607","volume":"312","author":"AE Slonim","year":"1985","unstructured":"Slonim AE and Goans PJ (1985) Myopathy in McArdle's syndrome: improvement with a high-protein diet. New Engl J Med 312: 355\u2013359","journal-title":"New Engl J Med"},{"key":"BFncpneuro0913_CR69","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/archneur.1990.00530040023014","volume":"47","author":"RF Kushner","year":"1990","unstructured":"Kushner RF and Berman SA (1990) Are high protein diets effective in McArdle's disease. Arch Neurol 47: 383\u2013384","journal-title":"Arch Neurol"},{"key":"BFncpneuro0913_CR70","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/ana.20881","volume":"59","author":"RG Haller","year":"2006","unstructured":"Haller RG  et al. (2006) Aerobic conditioning: an effective therapy in McArdle's disease. Ann Neurol 59: 922\u2013928","journal-title":"Ann Neurol"}],"container-title":["Nature Clinical Practice Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0913.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0913","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0913.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:34:13Z","timestamp":1684442053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":70,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["BFncpneuro0913"],"URL":"https:\/\/doi.org\/10.1038\/ncpneuro0913","relation":{},"ISSN":["1745-834X","1745-8358"],"issn-type":[{"value":"1745-834X","type":"print"},{"value":"1745-8358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}